Colorectal Cancer and Small Bowel AdenocarcinomaPhase 1NCT07417488
Lm-GUCY2C vaccine
GUCY2C Prime-Boost Vaccination for Advanced Colorectal and Small Bowel Adenocarcinomas
Fluorescence Image Guided Surgery Followed by Intraoperative Photodynamic Therapy for Improving Local Tumor Control in Patients With Locally Advanced or Recurrent Colorectal Cancer
What the film says
This trial is for adults with locally advanced or recurrent colorectal cancer who are having surgery.
The idea: patients take aminolevulinic acid, a light activated drug, by mouth before surgery. After the tumor is removed, fluorescence imaging checks the area, and then photodynamic therapy, using light, treats it during the same operation.
This phase 1 and 2 study plans 21 patients and aims to improve local tumor control. At Roswell Park Cancer Institute in Buffalo, Anthony Dakwar leads it.
Public record; not medical advice.
Sources behind this film
Adults; locally advanced or recurrent colorectal cancer undergoing surgery; Aminolevulinic acid by mouth before surgery; light activated; Fluorescence imaging after removal, then intraoperative PDT; Phase 1/2; 21 patients; improving local tumor control (+1 more lines)
The drug
PRIMARY OBJECTIVES: * To test the accuracy of image-guided fluorescence to detect residual disease. (Phase I) - completed * To determine the safety of intraoperative PDT after fluorescence-guided surgery in patients with loco-regionally advanced or recurrent colorectal cancer undergoing surgery. (Phase I) - completed * To determine the potential efficacy of intraoperative PDT (after image-guided fluorescence surgery). (Phase II) - SECONDARY OBJECTIVES: * To assess the relationship between disease free survival and changes in levels of carcinoembryonic antigen (CEA) and circulating tumor DNA (ctDNA). (Phase II) * To assess rate of recurrence by using standard-of-care computed tomography (CT) and/or magnetic resonance imaging (MRI). (Phase II) OUTLINE: Patients receive aminolevulinic acid orally (PO) 2 to 4 hours prior to standard of care (SOC) surgery.
Patients then undergo image-guided fluorescence 5-10 minutes post surgery, and intraoperative PDT 15-45 minutes post surgery. Patients also undergo computed tomography (CT) or magnetic resonance imaging (MRI) during screening and on follow up. Patients also undergo blood sample collection throughout the trial. After completion of study treatment, patients are followed up at 3 months, 24 weeks, and every 3 to 6 months for 3 years.
It is used to assist the surgeon to see cancer cells and small cancerous tissue that may have been missed during routine surgery. In addition to emitting fluorescence light, the converted drug in the cancer cells and tissue can be activated with red laser light to kill cancer cells. This procedure is called photodynamic therapy (PDT).
The study
*As of June 2026- Phase I has been completed and we are now in Phase II. This phase I/II trial studies the side effects and how well fluorescence image guided surgery followed by intraoperative photodynamic therapy for improving local tumor control in patients with colorectal cancer that has spread to nearby tissue or lymph nodes (locally advanced) or that has come back after a period of improvement (recurrent).
Fluorescence image guided surgery uses a drug named aminolevulinic acid hydrochloride. Aminolevulinic acid hydrochloride is a photosensitizing agent, meaning that is activated by light and, is converted to another drug in cancer cells more than in normal cells. The converted drug emits fluorescence red light when activated with low power blue light.
Eligibility
Inclusion criteria as written on the registry, trimmed. The full list, with exclusions, is on the live record.
For you, or someone you love
A complex diagnosis brings new questions every week, in a trial and out of one. Triangle keeps your whole medical file together, reads it with you in plain language, and helps you and your family decide what to ask next.
Then $9 a month. Cancel anytime.
Requested from your hospitals and clinics through the national networks. Add scans, pathology and anything on paper.
Reports explained as they come in, with lab values you can follow before treatment, during a trial and after.
Ask about your own file, and walk in with questions for your oncologist or the trial team.
Share one profile with the family helping you, and with your doctors.
Members also get a deeper analysis of their records and any sequencing data, including clinical trials that may fit, reviewed by a licensed physician before they receive it.
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.
How these trials work: what Phase 1 actually is · common questions Not clinical evidence.